Equities Analysts Offer Predictions for CRH Medical Corp’s FY2019 Earnings (CRHM)

CRH Medical Corp (NYSEAMERICAN:CRHM) – Beacon Securities issued their FY2019 earnings per share estimates for shares of CRH Medical in a report released on Monday, March 18th. Beacon Securities analyst D. Cooper forecasts that the company will earn $0.37 per share for the year. Beacon Securities also issued estimates for CRH Medical’s FY2020 earnings at $0.37 EPS.

CRH Medical (NYSEAMERICAN:CRHM) last posted its quarterly earnings results on Wednesday, March 13th. The company reported $0.02 earnings per share for the quarter, meeting the consensus estimate of $0.02. The business had revenue of $32.02 million for the quarter, compared to analyst estimates of $31.40 million.

Other research analysts have also issued reports about the company. Zacks Investment Research raised CRH Medical from a “hold” rating to a “buy” rating and set a $3.25 target price on the stock in a research report on Tuesday. TD Securities reaffirmed a “buy” rating on shares of CRH Medical in a research report on Tuesday, January 8th.

Shares of CRHM stock opened at $2.83 on Wednesday. CRH Medical has a fifty-two week low of $2.40 and a fifty-two week high of $4.50.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Nantahala Capital Management LLC boosted its stake in shares of CRH Medical by 6.1% during the 4th quarter. Nantahala Capital Management LLC now owns 6,534,155 shares of the company’s stock worth $20,028,000 after acquiring an additional 378,329 shares in the last quarter. Two Sigma Advisers LP boosted its stake in shares of CRH Medical by 12.6% during the 4th quarter. Two Sigma Advisers LP now owns 220,300 shares of the company’s stock worth $675,000 after acquiring an additional 24,700 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. boosted its stake in shares of CRH Medical by 21.7% during the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 2,201,799 shares of the company’s stock worth $6,739,000 after acquiring an additional 392,900 shares in the last quarter. Acadian Asset Management LLC boosted its stake in shares of CRH Medical by 163.9% during the 4th quarter. Acadian Asset Management LLC now owns 234,320 shares of the company’s stock worth $716,000 after acquiring an additional 145,520 shares in the last quarter. Finally, Beutel Goodman & Co Ltd. boosted its stake in shares of CRH Medical by 3.5% during the 4th quarter. Beutel Goodman & Co Ltd. now owns 5,127,100 shares of the company’s stock worth $1,570,000 after acquiring an additional 171,970 shares in the last quarter.

About CRH Medical

CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.

Further Reading: What is a Lock-Up Period?

Earnings History and Estimates for CRH Medical (NYSEAMERICAN:CRHM)

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit